CC-401 Promotes β-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition.

Autor: Abdolazimi Y; Department of Medicine, Division of Endocrinology, Stanford University, Stanford, California., Zhao Z; Biomedical Institute for Regenerative Research, Texas A&M University, Commerce, Texas., Lee S; Department of Medicine, Division of Endocrinology, Stanford University, Stanford, California., Xu H; Department of Medicine, Division of Endocrinology, Stanford University, Stanford, California., Allegretti P; Department of Medicine, Division of Endocrinology, Stanford University, Stanford, California.; Chemistry, Engineering and Medicine for Human Health Research Institute, Stanford University, Stanford, California., Horton TM; Department of Medicine, Division of Endocrinology, Stanford University, Stanford, California.; Chemistry, Engineering and Medicine for Human Health Research Institute, Stanford University, Stanford, California.; Department of Chemistry, Stanford University, Stanford, California., Yeh B; Department of Medicine, Division of Endocrinology, Stanford University, Stanford, California., Moeller HP; Department of Medicine, Division of Endocrinology, Stanford University, Stanford, California., Nichols RJ; Department of Genetics, Stanford University, Stanford, California., McCutcheon D; Department of Medicine, Division of Endocrinology, Stanford University, Stanford, California.; Chemistry, Engineering and Medicine for Human Health Research Institute, Stanford University, Stanford, California., Shalizi A; Department of Pathology, Stanford University, Stanford, California., Smith M; Chemistry, Engineering and Medicine for Human Health Research Institute, Stanford University, Stanford, California.; Medicinal Chemistry Knowledge Center, Chemistry, Engineering and Medicine for Human Health, Stanford University, Stanford, California., Armstrong NA; Department of Medicine, Division of Endocrinology, Stanford University, Stanford, California., Annes JP; Department of Medicine, Division of Endocrinology, Stanford University, Stanford, California.; Chemistry, Engineering and Medicine for Human Health Research Institute, Stanford University, Stanford, California.

Publikováno v: Endocrinology [Endocrinology] 2018 Sep 01; Vol. 159 (9), pp. 3143-3157.

Genetic Disruption of Adenosine Kinase in Mouse Pancreatic β-Cells Protects Against High-Fat Diet-Induced Glucose Intolerance.

Autor: Navarro G; Department of Medicine and Division of Endocrinology, Stanford University, Stanford, CA., Abdolazimi Y; Department of Medicine and Division of Endocrinology, Stanford University, Stanford, CA., Zhao Z; Department of Medicine and Division of Endocrinology, Stanford University, Stanford, CA., Xu H; Department of Medicine and Division of Endocrinology, Stanford University, Stanford, CA.; Department of Endocrinology and Metabolism, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China., Lee S; Department of Medicine and Division of Endocrinology, Stanford University, Stanford, CA., Armstrong NA; Department of Medicine and Division of Endocrinology, Stanford University, Stanford, CA., Annes JP; Department of Medicine and Division of Endocrinology, Stanford University, Stanford, CA jannes@stanford.edu.

Publikováno v: Diabetes [Diabetes] 2017 Jul; Vol. 66 (7), pp. 1928-1938. Date of Electronic Publication: 2017 May 03.

Repurposing cAMP-modulating medications to promote β-cell replication.

Autor: Zhao Z; Department of Medicine and Division of Endocrinology, Gerontology, and Metabolism (Z.Z., N.A.A., S.A.S., J.P.A.) and Stanford Center for Biomedical Informatics Research (Y.S.L.), Stanford University School of Medicine, Stanford, California 94306; Department of Stem Cell and Regenerative Biology (J.H.R., A.C.A.), Harvard University, Cambridge, Massachusetts 02138; and Section of Islet Cell and Regenerative Biology (J.H.-L., G.C.W.), Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115., Low YS, Armstrong NA, Ryu JH, Sun SA, Arvanites AC, Hollister-Lock J, Shah NH, Weir GC, Annes JP

Publikováno v: Molecular endocrinology (Baltimore, Md.) [Mol Endocrinol] 2014 Oct; Vol. 28 (10), pp. 1682-97. Date of Electronic Publication: 2014 Aug 01.

Study on the reduction of chemotherapy induced neutropenia in mice using glucosaminylmuramyl dipeptide.

Autor: Armstrong NA; University of New South Wales, Department of Surgery, St. George Hospital, Sydney, Australia., Bolton EJ, Morris DL

Publikováno v: Arzneimittel-Forschung [Arzneimittelforschung] 1999 Aug; Vol. 49 (8), pp. 716-20.

The formation of lactose plugs for hard shell capsule fills.

Autor: Tattawasart A; Welsh School of Pharmacy, University of Wales, Cardiff, United Kingdom., Armstrong NA

Publikováno v: Pharmaceutical development and technology [Pharm Dev Technol] 1997 Nov; Vol. 2 (4), pp. 335-43.